WUXI YAOMING UNITED BIOTECHNOLOGY CO. LTD
{{company.company_channel.channel_name}}
Media Room
{{company.company_name_local}}
{{company.company_channel.channel_name}}
Company Profile
Media Room
The 2025 BPD Singapore Conference Has Concluded Successfully! Jointly Embarking on a New Journey for Global Development 2025-09-27 10:45
WuXi XDC Included in MSCI China All Share Index 2025-08-08 17:32
WuXi XDC Achieves GMP Release of Newly Launched DP3 Facility at Wuxi Site, Scaling Further Drug Product Manufacturing Capacity 2025-08-05 10:13
WuXi XDC Announces the Mechanical Completion of its Singapore Site, Accelerating the Global Expansion of Bioconjugates Manufacturing 2025-07-01 17:44
WuXi XDC Received Multiple Awards from 2025 Extel (previously "Institutional Investor") Ranking in Diverse Categories 2025-05-20 09:44
WuXi XDC Achieved Another Remarkable Year with Extraordinary Business Performance and Financial Results for 2024 2025-03-24 22:45
WuXi XDC Wins Multiple Awards at Asia-Pacific Biopharma Excellence Awards 2025 2025-03-13 13:54
WuXi XDC and AbTis Announce Strategic Partnership to Advance Next-Generation ADCs 2025-03-11 21:20
WuXi XDC and LigaChem Biosciences Strengthen Partnership with Expanded MOU to Accelerate ADC Development 2025-02-25 18:34
WuXi XDC Named Best CDMO Winner at 2024 World ADC Awards 2024-11-08 11:27
WuXi XDC Reports Strong Business Updates with Superior Financial Results in 1H 2024: Poised for Future Growth 2024-08-20 23:05
WuXi XDC Delivers Outstanding Performance in 2023 with over 110% Year-On-Year Growth for Both Revenue and Adjusted Net Profit and Achieves Significant Corporate Milestones 2024-03-25 21:39
WuXi XDC Enters into Partnership with Multitude Therapeutics and HySlink Therapeutics, Novel Linker-Payload Technology Enabling Clients to Accelerate ADC Discovery and Development 2024-01-31 10:43
WuXi XDC and Celltrion Sign MOU for Integrated Services for Antibody-Drug Conjugates (ADCs) 2024-01-24 11:37
WuXi XDC Enters into Partnership Agreement with IntoCell, Enabling Clients to Accelerate ADC Discovery and Development 2024-01-03 09:28
WuXi XDC Successfully Listed on the Main Board of Hong Kong Stock Exchange 2023-11-17 14:00
WuXi XDC Named Best CDMO Winner at 2023 World ADC Awards 2023-10-20 16:00
WuXi XDC and HKSTP Join Forces to Promote Development of Bioconjugate Drug Industry in Hong Kong 2023-10-18 11:00
WuXi XDC Launches New Commercial Manufacturing Facilities 2023-09-20 18:51
WuXi XDC and Boostimmune Sign MOU for Integrated Services 2023-08-11 08:30
1